Jump to content

Martin Dow

From Wikipedia, the free encyclopedia

Martin Dow
Company typePrivate
IndustryPharmaceutical
Founded1995; 29 years ago (1995)
FounderMuhammad Jawed Akhai
HeadquartersKarachi, Pakistan
Area served
Asia, Middle East, Europe, Africa
ProductsADVIT-D, BUSCOPAN PLUS, CONCOR, GLUCOPHAGE, INFEXIN CAPS, KLARIBACT, MERCIP, NEUROBION, POLYBION, ROZANTO, SANGOBION, TIXOMER, VONOSPIRE, WINTOGENO
RevenueIncrease Rs. 5000 crore (US$170 million) (2021)[1]
Number of employees
1,000+ [2]
SubsidiariesMartin Dow Limited
Martin Dow Marker Ltd.
Martin Dow Specialities (Pvt.) Ltd.
Martin Dow Pharmaceuticals (France)
Websitemartindow.com

Martin Dow is a Pakistani multinational pharmaceutical company which is based in Karachi. It was founded in 1995[3][4] and has six manufacturing facilities in Pakistan[5] and one in France.[6]

History

[edit]

Martin Dow was founded in 1995 and began operations in 2000 with a small manufacturing facility in Lahore.[7]

In 2010, Martin Dow acquired the manufacturing facility and brands of Roche Pakistan.[8]

In 2015, Martin Dow was recognized as a Global Growth Company by the World Economic Forum.[9] In the same year, Martin Dow entered into an alliance with Biocodex S.A., a France-based pharmaceutical company.[10]

In 2016, German Merck KGaA executed a binding contract to divest its shareholding in Pakistan to Martin Dow Ltd.[11][12][13]

In 2016, in a €1.5 million deal, Martin Dow acquired the Laboratoires Salem (before 2010 Bristol-Myers Squibb) pharmaceutical manufacturing facility in Meymac, France.[14][15] In March 2017, the French President Francois Hollande inaugurated Martin Dow Pharma's Meymac Plant in France.[16][17] The plant of V2Pharm in Gien, France was also taken over by Martin Dow.[18]

In 2020, Martin Dow was awarded for excellent performance in fire safety and protection by the Sindh local government minister.[19]

Controversy

[edit]

In 2016, the National Accountability Bureau (NAB) arrested two directors of Martin Dow because it wrongfully derived financial benefits on the basis of illegal price increase.[20][21][22]

References

[edit]
  1. ^ "Martin Dow Limited" (PDF). The Pakistan Credit Rating Agency Limited. Retrieved 29 February 2024.
  2. ^ "CORPORATE PROFILE". Martin Dow. Retrieved 31 December 2016.
  3. ^ "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. Martin Dow was established in 1995 initially as a pharmaceutical marketing company in Karachi (Pakistan)
  4. ^ "Martin Dow - Corporate Profile". Martin Dow.
  5. ^ bhooto, bilawal (21 November 2016). "A strategic relationship". Dawn. Retrieved 31 December 2016. With the acquisition of Merck Pakistan, Martin Dow will have six manufacturing facilities in the country.
  6. ^ Mettis, Global (29 March 2019). "Martin Dow Pakistan adds state of art manufacturing facility in France". Mettis Global Link. Retrieved 22 August 2024.
  7. ^ Baig, Mariam Ali (23 April 2021). "Interview: Javed Ghulam Mohammad, Group MD & CEO, Martin Dow Group". Aurora Magazine.
  8. ^ "Martin Dow - Company Profile". Business Recorder. 15 July 2012. Retrieved 28 December 2016.
  9. ^ "List of Global Growth Company Members" (PDF). World Economic Forum. Retrieved 30 December 2016.
  10. ^ "Treating illness: Martin Dow, Biocodex ink alliance". Express Tribune. 12 March 2015. Retrieved 2 January 2017.
  11. ^ "German pharma giant divests interests". The Express Tribune. PPI. 8 November 2016. Retrieved 28 December 2016.
  12. ^ "Merck divests its Pakistan stake to Martin Dow". Dawn. 8 November 2016. Retrieved 28 December 2016.
  13. ^ "Martin Dow acquires Merck operations in Pakistan". The News International. 8 November 2016. Retrieved 28 December 2016.
  14. ^ "Pakistani pharmaceutical company to operate in France". Business Recorder. 21 August 2016. Retrieved 30 December 2016. A Pakistani Pharmaceutical company, Martin Dow has acquired a pharmaceutical manufacturing facility in Meymac, France. The facility was earlier owned by the renowned pharmaceutical firm Bristol-Myers Squibb.
  15. ^ Mérigaud, Corinne (3 December 2015). "Laboratoires Salem repris par le pakistanais Martin Dow". L'Usine Nouvelle. Retrieved 30 December 2016.
  16. ^ "French President to inaugurate Pakistani Pharma Plant in France". The Nation. Retrieved 3 January 2017.
  17. ^ "Inauguration of Martin Dow plant by the French President (Meymac, 16 March 2017)". La France au Pakistan - Ambassade de France au Pakistan. Retrieved 1 April 2019.
  18. ^ "L'ancien site de V2Pharm à Gien va être repris". La Republique. 1 July 2015. Retrieved 3 January 2017.
  19. ^ "Sindh LG Minister Nasir Shah gives Fire Safety Awards to 43 companies". Daily Times. 22 December 2020. Retrieved 1 January 2021.
  20. ^ "Drug business: NAB arrests 8 involved in mega corruption". The Express Tribune. 23 November 2016.
  21. ^ "NAB arrests eight in drug price-hike cases". The Nation. 23 November 2016.
  22. ^ "NAB arrests top bureaucrat in illegal drugs price hike case". Daily Times (Pakistan). 25 November 2016.